Isabel Kalofonos Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

Isabel Kalofonos is Chief Commercial Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 834 shares of CRNX, which is worth approximately $36,295. The most recent transaction as insider was on Jan 05, 2026, when has been sold 2,500 shares (Common Stock) at a price of $55.0 per share, resulting in proceeds of $137,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 834

n/a 3M change

n/a 12M change

Total Value Held $36,295

Isabel Kalofonos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 05 2026	SELL Open market or private sale	$137,500 $55.0 p/Share	2,500 Reduced 74.99%	834 Common Stock
Jan 05 2026	BUY Exercise of conversion of derivative security	$101,475 $40.59 p/Share	2,500 Added 42.85%	3,334 Common Stock

Also insider at

IMGN

ImmunoGen, Inc. Healthcare

SVP & CHIEF COMMERCIAL OFFICER